Syncona Limited Appointment of Joint Corporate Broker (1926N)
16 January 2019 - 6:00PM
UK Regulatory
TIDMSYNC
RNS Number : 1926N
Syncona Limited
16 January 2019
16 January 2019
Syncona Limited ("Syncona")
Appointment of Joint Corporate Broker
Syncona is pleased to announce that it has appointed Goldman
Sachs International with immediate effect as joint Corporate Broker
alongside Numis Securities, who remain joint Corporate Broker.
END
Enquiries:
Investor enquiries
Annabel Clay
Tel: +44 (0) 20 3981 7940
Goldman Sachs Numis Securities
Charlie Lytle Nathan Brown
Tom Hartley James Black
Lucy Clarke Freddie Barnfield
Tel: +44 (0) 207 774 1000 Tel: +44 (0) 207 260 1000
About Syncona
Syncona is a leading FTSE250 healthcare company focused on
founding, building and funding global leaders in life science. Our
vision is to deliver transformational treatments to patients in
truly innovative areas of healthcare while generating superior
returns for shareholders.
We seek to partner with the best, brightest and most ambitious
minds in science to build globally competitive businesses.
We take a long-term view, underpinned by a deep pool of capital,
and are established leaders in gene and cell therapy. We focus on
delivering dramatic efficacy for patients in areas of high unmet
need.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
APPCKPDKCBKDCDD
(END) Dow Jones Newswires
January 16, 2019 02:00 ET (07:00 GMT)
Syncona (LSE:SYNC)
Historical Stock Chart
From Apr 2024 to May 2024
Syncona (LSE:SYNC)
Historical Stock Chart
From May 2023 to May 2024